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Employment Opportunities
Staff Scientist at SEGEN/DEB, NICHD.—A staff scientist po-
sition is available in the Section on Genetics and Endo-
crinology, Developmental Endocrinology Branch (SEGEN/
DEB), of the National Institute of Child Health and
Human Development (NICHD) to study the molecular
consequences of protein kinase A signaling–system ab-
normalities in adrenal, pituitary, and other endocrine and
nonendocrine tumors, by use of human-genetics ap-
proaches and transgenic models of PKA and related en-
zymes (i.e., PDEs) that will elucidate this system’s inter-
actions with other major tumorigenic and developmental
signaling pathways (see also Nat Genet 26:89–92 [2000]
and 38:794–800 [2006]). A strong background in molec-
ular biology and genetics is required. Applicants must
have at least a Ph.D. and should have 15 years of post-
doctoral experience in animal and endocrinology re-
search, gene therapy, or a related ﬁeld. Candidates should
send a curriculum vitae, a bibliography, and contact de-
tails (including phone numbers and e-mail addresses) of
at least two referees to Constantine Stratakis, M.D., Sc.D.,
Chief, SEGEN/DEB, NICHD, NIH, Building 10 (CRC),
Room 1-3330 (East Labs), 10 Center Drive, MSC 1103,
Bethesda, MD 20892; e-mail: stratakc@mail.nih.gov. The
position will be available after October 1, 2006, and ap-
plications will be accepted until September 30, 2006. The
Department of Health of Human Services and theNational
Institutes of Health are equal opportunity employers.
Clinical Cytogeneticist.—The Cytogenetics Department of
the Nichols Institute at Quest Diagnostics, Inc., seeks an
experienced clinical cytogeneticist to join the team-ori-
ented management team of their expanding full-service
laboratory. The candidate should hold a Ph.D. or M.D.
degree and should be board certiﬁed (or board eligible) in
clinical cytogenetics by the American Board of Medical
Genetics. Clinical responsibilities will include interpret-
ing, reporting, and consulting on a diverse spectrum of
prenatal, postnatal, and oncology cytogenetics and mo-
lecular cytogenetics tests. Quest Diagnostics Nichols In-
stitute is located in Chantilly, VA, near metropolitan
Washington, DC. Full beneﬁts offered by Quest Diagnos-
tics include medical and dental insurance, 401(k) (match-
ing 6%), an employee stock program, and other incen-
tives, such as on-site cafeteria and child-care facilities.
Quest Diagnostics offers a competitive salary and rank
commensurate with experience and qualiﬁcations. Please
apply online (http://www.questdiagnostics.com/) and at-
tach your resume and cover letter. If you have any
questions or would like more information about this
announcement, please contact Philip Mowrey, Ph.D.,
FACMG, Quest Diagnostics Nichols Institute, 14225 New-
brook Drive, Chantilly, VA 20153-0841; telephone: (800)
336-3718 x7094; fax: (703) 802-7103; e-mail: Philip.n
.mowrey@questdiagnostics.com. Quest Diagnostics is an
equal opportunity employer.
Research Associate Professor.—The Department of Pediatrics
at the University of Pennsylvania’s School of Medicine
seeks candidates for an associate professor position in the
nontenure research track. The successful applicant will be
accomplished in genetics and/or molecular biology. Ap-
plicants must have an M.D. and/or Ph.D. degree andmust
be able to demonstrate excellent qualiﬁcations in research.
We are looking for candidates with at least 5 years expe-
rience in large-scale microsatellite/SNP genotyping and
human genetics research to manage the operational ac-
tivities at the Center for Applied Genomics at The Chil-
dren’s Hospital of Philadelphia. The successful candidate
will work closely with the Center Director andwill provide
day-to-day supervision and management of the Center’s
activities, including DNA isolation and SNP-chip process-
ing workﬂows, together with data mining and data anal-
ysis. Key emphases will be on automation, throughput,
and quality-control measures at all levels of data process-
ing, together with effective data-mining procedures. The
successful candidate will be expected to apply for inde-
pendent research support and to establish and grow his
or her own career. The University of Pennsylvania is an
equal opportunity, afﬁrmative action employer. Women
andminority candidates are strongly encouraged to apply.
Please submit a curriculum vitae and a letter of interest to
Beverly Emanuel, Ph.D., Professor of Pediatrics, University
of Pennsylvania School of Medicine, Chief, Division of
Human Genetics, The Children’s Hospital of Philadelphia,
3615 Civic Center Boulevard, Room 1002, ARC Building,
Philadelphia, PA 19104.
Clinical Cytogeneticist Position.—The Permanente Medical
Group of Kaiser Northern California is seeking a clinical
cytogeneticist assistant/codirector for our laboratoryman-
agement team. Kaiser Permanente is one of the largest
HMO health care systems in the U.S. The Northern Cal-
ifornia program provides integrated, comprehensive ge-
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netics services through ﬁve genetics centers and a regional
cytogenetics/molecular genetics laboratory. Located in
San Jose, the heart of Silicon Valley, 50 miles from San
Francisco and the Paciﬁc coast, our full-service diagnostic
cytogenetics lab processes 112,000 prenatal, constitu-
tional, and oncology cases annually, with a signiﬁcantmo-
lecular cytogenetics component. An M.D. or Ph.D. in a
ﬁeld related to genetics, completion of a 2-year ABMG-
approved training program, ABMG certiﬁcation in clinical
cytogenetics, and eligibility for California state licensure
are required. To apply, please send a curriculum vitae and
a letter of interest to Leigh Conley, Senior Staff Assistant,
Genetics Department, 5755 Cottle Road, Building One,
San Jose, CA 95123; telephone: (408) 972-3342; fax: (408)
972-3298; e-mail: Leigh.Conley@KP.org. We are an equal
opportunity/afﬁrmative action employer.
Postdoctoral Position in Statistical Genetic Analysis and Ge-
netic Epidemiology.—The Genetics of Complex Disorders
(GCD) training program in the Department of Psychiatry
at Columbia University provides pre- and postdoctoral
training in the genetic epidemiology and statistical genetic
analysis of complex diseases, including psychiatric dis-
orders. Our mission is to train scientists who will be aware
of all aspects of genetic studies, including study design,
clinical aspects, phenotype deﬁnition, molecular labora-
tory issues, and statistical analysis. Training includes both
didactic (i.e., coursework and lab rotations) and research
components. We currently have one postdoctoral open-
ing. We seek an applicant with a demonstrated interest
in pursuing a career in the genetic analysis of complex
disorders, preferably also with training in statistics, medi-
cine, epidemiology, and/or genetics. Applicants must
have a Ph.D., M.D., or equivalent degree. Further infor-
mation can be obtained at our Web site (http://cpmcnet
.columbia.edu/dept/sph/epi/gcd/) or from Susan E.
Hodge, D.Sc, NYSPI, Unit 24, 1051 Riverside Drive, New
York, NY 10032. Columbia University is an afﬁrmative
action/equal opportunity employer. Applicants must be
U.S. citizens or permanent resident aliens.
Clinical Geneticist.—The Department of Medical Genetics
at Mayo Clinic in Rochester, MN is seeking a full-time
board-certiﬁed/board-eligible clinical geneticist with spe-
cial expertise or interest in patients with inborn errors of
metabolism. Board eligibility in biochemical genetics is
desired but not necessary. The successful candidate will
join our department of six clinical geneticists, 15 labo-
ratory geneticists, 11 genetics counselors, and alliedhealth
support staff. The focus of practice will be patients with
metabolic conditions, as well as general genetics condi-
tions. Mayo Clinic’s Department of Medical Genetics has
several multidisciplinary clinics, strong working connec-
tions with the Department of Laboratory Medicine and
Pathology, and genetics laboratories which provide state-
of-the-art diagnostics and clinical care to patients with a
variety of genetic conditions. The successful candidatewill
coordinate and further develop the already established
Mayo Clinic Metabolic Program. The Department of Med-
ical Genetics is integrated with the 150 clinical depart-
ments and divisions, providing care to an interesting,
challenging, and diverse group of patients fromour region
and around the world. Practice opportunities range from
developing a community-based practice to international
consultation. The successful candidate will enjoy close
clinical collaboration with pediatricians, neurologists, en-
docrinologists, surgeons, and practitioners from multiple
other disciplines. Opportunities to conduct research and
to teach medical students, residents, fellows, visiting cli-
nicians, and allied health professionals are essential com-
ponents of the position. Candidates should be clinicians
committed to an academic career with a focus in meta-
bolic errors, as well as embracing Mayo Clinic’s values of
teamwork and collaboration. The faculty member will
have an academic appointment commensurate with prior
background in The Mayo Clinic College of Medicine.
Please send your letter of interest, curriculum vitae, and
two references to Dusica Babovic-Vuksanovic,M.D.,Chair,
Department of Medical Genetics, Mayo Clinic, 200 1st
Street SW, Rochester, MN 55905; e-mail: dbabovic@mayo
.edu
Fellowship in Medical Genetics and Pediatric Endocrinology.—
A combined medical genetics and pediatric endocrinology
fellowship that will lead to certiﬁcation by both the Amer-
ican Board of Medical Genetics and the American Board
of Pediatrics Sub-Board on Pediatric Endocrinology after
5–6 years of training (after approval by each Board) is
being sponsored by the Heritable Disorders Branch of the
National Institute of ChildHealth&HumanDevelopment
(NICHD). Clinical training will take place within the con-
text of the Accreditation Council for Graduate Medical
Education (ACGME)-approved Pediatric Endocrinology
andMedical Genetics fellowship programs of the National
Institutes of Health (NIH) and sponsored by the NICHD
and the National Human Genome Research Institute
(NHGRI). Graduates of a pediatrics or a combined pedi-
atrics/internal medicine ACGME-approved residency pro-
gram in the United States are eligible. We encourage both
applicants with previous Ph.D. training and graduates of
an M.D./Ph.D. program to apply for this unique fellow-
ship, which aims at bridging two very relevant subspe-
cialties of pediatric medicine: genetics and endocrinology.
This is an exciting opportunity for a physician-scientist in
training who wants to take advantage of the exciting op-
portunities offered by the NIH Clinical Center, the hun-
dreds of state-of-the-art research laboratories at the NIH
campus, and the commitment of NIH leadership in train-
ing initiatives on translational research. Interested can-
didates should send a cover letter, a curriculum vitae,
and the names of at least three references to Constantine
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A. Stratakis, M.D., D.Med.Sci., Chief, Heritable Disorders
Branch, NICHD, NIH, and Director, Pediatric Endocrinol-
ogy Training Program, NICHD, NIH, 10 Center Drive,
Building 10, Room 9D42,MSC 1830, Bethesda,MD20892;
telephone: (301) 496-6683; fax: (301) 480-0378; e-mail:
stratakc@mail.nih.gov. For more information, visit the Pe-
diatric Endocrinology Training Program Web site (http://
www.pediatricendocrinology.nichd.nih.gov/index.html)
or call Janet Krasnican at (301) 496-6683.
Research Fellow.—A postdoctoral position studying inher-
ited genetic variation in cancer is available in the Cancer
Biology and Genetics program at the Memorial Sloan-Ket-
tering Cancer Center in New York City. We use genome-
wide association studies as a primary tool to identify ge-
netic variants that inﬂuence cancer phenotypes. We take
an integrated approach, combining statistical genetics,
bioinformatics and computational genomics, and molec-
ular biology in the design, performance, and analysis of
such studies. This position mainly involves computer-
based statistical genetics and bioinformatics analysis,
though the opportunity for some hands-on experimental
work exists as well. Therefore, the ideal candidatewill have
a demonstrated interest and aptitude in quantitative
methods, as well as a background in genetics or a related
ﬁeld. Further information about the lab can be found at
its Web site (http://www.mskcc.org/mskcc/html/68781
.cfm). Questions or a curriculum vitae can be sent to
kleinr@mskcc.org
Meetings
12th and 13th Annual International Scientiﬁc Meetings of the
Velo-Cardio-Facial Syndrome Educational Foundation.—The
Velo-Cardio-Facial Syndrome Educational Foundation,
Inc., will be holding its second meeting for this year in
Brisbane, Australia, on November 2–4, 2006. The meeting
will be cosponsored and hosted by The VCFS Foundation
(Qld), Inc. The international and interdisciplinary faculty
at the meeting is being assembled and will include emi-
nent researchers and clinicians covering the latest research
in genetics and genomics, speech and feeding disorders,
surgical outcomes, psychiatric illness, neural imaging, de-
velopment, and education, among other topics. Details
will follow in the coming months and will be available at
the Web sites of the Educational Foundation (http://
www.vcfsef.org) and The VCFS Foundation (Qld), Inc.
(http://www.vcfs.com.au). The meeting is open to all pro-
fessionals and laypeople with an interest in the disorder.
The Velo-Cardio-Facial Syndrome Educational Founda-
tion, Inc., is an international alliance of professionals and
laypeople whose mission is to spread information about
VCFS (also known as “DiGeorge syndrome” and “deletion
22q11 syndrome”) and to advocate for people with the
disorder. The annual meetings of the Educational Foun-
dation have reached 13,000 professionals and laypeople
since the ﬁrst meeting in 1995.
Conferences
WORLD (We’re Organizing Research on Lysosomal Diseases)
Symposium 2006.—The 3rd annual conference will be pre-
sented by the Lysosomal Disease Network in partnership
with Dr. Chet Whitley, a professor in the Department of
Pediatrics at the University of Minnesota, on December
7–9, 2006, at Disney’s Contemporary Resort in Orlando,
FL. The goal of the annual symposium is to provide an
interdisciplinary forum to explore and discuss speciﬁc
areas of interest related to lysosomal diseases. The sym-
posium is appropriate for clinicians, geneticists and gen-
etic counselors, neurologists and neuropsychologists,
researchers, nurses, and other health care professionals, as
well as patients and families, patient/family support or-
ganizations, and industry professionals. Disease focuses
will include mucopolysaccharidosis, mucolipidosis, oli-
gosaccharidosis, Fabry disease, Batten disease, Gaucher
disease, Pompe disease, and sphingolipidoses. The dead-
line for abstracts is July 1, 2006; for abstract submission,
use the Lysosomal Disease Network Web site (http://
www.lysosomaldiseasenetwork.org). To register, visit the
University of Minnesota’s Continuing Medical Education
Web site (http://www.cme.umn.edu), click “Course Cal-
endar,” and scroll to “WORLD Symposium,” or else con-
tact the University of Minnesota by telephone, at (612)
626-7600 or (800) 776-8636. To make hotel reservations,
call (407) 824-3869, and be sure to mention the WORLD
symposium to receive a discounted room rate. For more
information, contact the Ofﬁce of ContinuingMedical Ed-
ucation at the URL or telephone numbers above or by e-
mail (cmereg@umn.edu). A complete brochure with a de-
tailed agenda will be available this summer. TheUniversity
of Minnesota is accredited by the Accreditation Council
for Continuing Medical Education (ACCME) to provide
continuing medical education to physicians.
Cerebellar Development: Bench to Bedside 2006 International
Conference.—This conference will be held at the L’Enfant
Plaza Hotel inWashington D.C. on November 9–12, 2006.
The conference will address human disorders and animal
models, focusing mainly on mouse and zebraﬁsh. Session
topics will include but are not limited to delineation of
syndromes, gene identiﬁcation, molecular analysis, pre-
natal diagnosis, cerebellar patterning, cell speciﬁcation,
neuronal migration, and genetic pathways. We will also
host a poster session and provide a printed program, with
a review of the conference to be published in a basic-
science journal. The conference is funded by a grant from
the National Institutes of Health, as well as private foun-
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dations and patient advocacy groups, with the goal of
advancing knowledge of disorders of cerebellar develop-
ment. The conference is being organized by Joseph G.
Gleeson, William B. Dobyns, and Enza-Maria Valente. We
anticipate 100 attendees for our inaugural conference. For
more information, please see the conference Web site
(http://cerebellardevelopment.ucsd.edu/).
DNA Samples Available
DNA Samples with Multiply Veriﬁed Mutations Available from
NIGMS Cell Repository.—The National Institute of General
Medical Sciences (NIGMS)HumanGenetic Cell Repository
at the Coriell Institute for Medical Research is collaborat-
ing with the Genetic Testing Quality Control Materials
Program (GTQC) of the Centers for Disease Control and
Prevention (CDC) to distribute quality control (QC) ma-
terials to the genetics community. These QC materials
contain mutations of clinical importance that have been
conﬁrmed by multiple volunteer laboratories by use of
different testing platforms. Samples currently available in-
clude: Huntington disease; Bloom syndrome; Canavan
disease; Fanconi anemia, group C; familial dysautonomia;
Gaucher disease; glycogen storage disease; mucolipidosis
type IV; Niemann-Pick disease, types A and B; and Tay-
Sachs disease. Results of the analyses from the different
laboratories that conﬁrmed the mutations, as well as the
methods used by those laboratories, are available at the
Coriell Cell Repositories Web site (http://ccr.coriell.org/
nigms/special/qc_material.html) and the CDC Web site
(http://www.phppo.cdc.gov/dls/genetics/qcmaterials/).
The collaboration between the NIGMS Repository and the
GTQC program to develop QC materials is an ongoing
project, and development of additional disorders is being
planned. Disorders for which QC materials are currently
being developed include fragile X syndrome.DNA samples
are available from the NIGMS Repository. Information
about ordering materials is available at the NIGMS Hu-
man Genetic Cell Repository Web site (http://ccr.coriell
.org/nigms/). See the NIGMS assurance form (http://ccr
.coriell.org/nigms/comm/order/assurance.pdf) for an ex-
planation of the appropriate use of the material.
Colloquium
Genomewide Association Studies: Design and Analysis.—The
Yale School of Public Health’s Department of Epidemiol-
ogy will be holding an international colloquium on ge-
nomewide association studies in New Haven, CT, on Oc-
tober 26–27, 2006. Genomewide association studies are
increasingly utilized but with little consensus on optimal
research design and analysis strategies. These studies in-
clude large arrays of candidate genes, as well as hypothesis-
free strategies involving several hundred thousand poly-
morphisms. Critical and sometimes controversial issues in
designing and analyzing both types of study will be ex-
amined. The conference also explores novel technological
developments thatmake genomewide studies possible and
population genetics that must be considered for proper
interpretation. These issues will be discussed in the con-
text of ongoing genomewide association studies. Partici-
pants will learn the latest methods for designing and
analyzing genomewide studies for associating genetic
polymorphisms with risk of complex disease. The course
directors are Michael B. Bracken, Ph.D., Yale University,
and Hongyu Zhao, Ph.D., Yale University. The faculty
will include Goncalo Abecasis, Ph.D., University of Michi-
gan; David Altshuler, Ph.D., Harvard University; Michael
Boehnke, Ph.D., University of Michigan; Aravinda Chak-
ravarti, Ph.D., Johns Hopkins University; Andrew Clark,
Ph.D., Cornell University; David Clayton, Ph.D., Cam-
bridge University; David Cox, M.D., Ph.D., Perlegen Sci-
ences; Nancy Cox, Ph.D., University of Chicago; Peter
Donnelly, Ph.D., Oxford University; Robert Elston, Ph.D.,
Case Western Reserve University; Josephine Hoh, Ph.D.,
Yale University; Ted Holford, Ph.D., Yale University; Ken-
neth K. Kidd, Ph.D., Yale University; Richard Lifton,M.D.,
Ph.D., Yale University; Perry Miller, M.D., Yale University;
Newton Morton, Ph.D., University of Southampton; Jurg
Ott, Ph.D., Rockefeller University; Jonathan Pritchard,
Ph.D., University of Chicago; Harvey Risch, Ph.D., M.D.,
Yale University; Jonathan Rothberg, Ph.D., 454 Life Sci-
ences; Eric Schadt, Ph.D., Rosetta Inpharmatics; and Pak
Sham, Ph.D., University of Hong Kong. For more infor-
mation or to register for the conference, please visit our
Web site (http://cme.yale.edu/). You can also contact Yale
CME at cme@yale.edu or (203) 785-4578.
ISCN Committee Formed
ISCN Committee Members, 2007–2011.—The newly elected
committee for the International System for Human Cy-
togenetic Nomenclature (ISCN) has been formed. The
committee consists of 11 elected members from six geo-
graphical locations. The following individuals will serve
on the ISCN committee for 2007–2011: Myriam Chaa-
bouni (Africa/Middle East); Yoshimitsu Fukushima and
Prochi Madon (Asia); Lynda Campbell (Australia), Chris-
tine Harrison, Nils Mandahl, and Albert Schinzel (Europe);
Kathleen Rao, Marilyn Slovak, and Lisa Shaffer (North
America); and Carla Rosenberg (Latin America).
